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INTRODUCTION Juvenile myelomonocytic leukemia (JMML) is characterized by clinical 
and laboratory features including : splenomegaly, thrombocytopenia, presence of myeloid 
precursors in peripheral blood, less than 20% blasts in bone marrow, elevated HbF and 
in vitro hypersensitivity to GM-CSF stimulation. Pathophysiology lies on excessive growth 
of myeloid progenitors, usually associated with overactivation of Ras pathway. It has been 
clinically linked to neurofibromatosis type I and Noonan syndrome.
RESULTS We report a 5 months old boy, who presented with enlarged spleen, 
thrombocytopenia, elevated HbF, presence of myeloid precursors in the peripheral blood. 
Bone marrow analysis excluded other forms of myeloproliferation including AML, t9,22. 
Addiional features were macrocephaly with external hydrocephaly, short stature (lower than 
P3) and low IgG level (0,6 g/L). Though hypersensitivity to GM-CSF was proven, none of the 
JMML causing genes was mutated. JMML diagnosis was confimed. Later on, he developed 
refractory hypocalcemia (lower than 7 mg/dl) despite normal vitamin D status. Bone Xray 
finally allow us to diagnose autosomic recessive malignant osteopetrosis, that recapitulates 
all clinical signs. Allogenic hematopoietic stem cell transplantation was performed.
CONCLUSION Osteopetrosis (OP) can present as JMML, mainly due to extramedullary 
hematopoiesis. HbF is also increased in that situation. It is not clear if GM-CSF hypersensitivity 
is present in majority of OP. As other suggested it, hypogammaglobulinemia is not a feature 
of JMML and should prompt to reconsider diagnosis. In addition to medullary insufficiency, 
disturbance of immunoglobulin synthesis worsens immune deficiency in OP. JMML workup 
should also take into account possibility of osteopetrosis.
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INTRODUCTION Treatment of childhood obesity is not universally succesfull. Identification of 
factors associated with treatment failure can help to identify patients groups needing more 
intensive or tailored follow-up.
AIM . As part of a larger prospective study on the identification of predictors of success 
or failure of residential treatment in childhood obesity, the aim of this study is to evaluate 
whether developing overweight at an earlier age (so-called early adiposity rebound) is 
associated with less weight loss during 9 -12 months of residential treatment.
METHOD The study population consists of 62 adolescents (12-18 year), out of 181, who 
were treated for obesity in the Zeepreventorium De Haan during 2007-2009 by a multi-
component residential program. Inclusion criteria (dutch-speaking, informed consent given, 
school history traceable) were present in 68 children. Weight and height data at start, 
during and at the end of treatment were obtained from the files in the Zeepreventorium. By 
contacting the CLB (“centra leerlingenbegeleiding”) growth curves were completed in 62 
patients, data from 6 patients could not be traced. Overweight at the age of 6 y was defined 
by a BMI > 2 Z-score above median for age. Spearman correlation for continuous variables 
and Fisher exact test for categorical variables were used to test the study hypothesis.
RESULTS No correlation was found between being overweight at the age of 6 and the result 
of residential treatment at 6 months (p=0.962, r=-0.007) or at 9-12 months (p=0.575, 
r=-0.73). Of the 24 children with a BMI z-score < 2 at 6 year, only one didn’t have a normal 
BMI after treatment. Of the 38 children with a BMI z-score > 2, seven didn’t achieve a 
normal BMI. The difference between these groups is not significant (p=0.136). Furthermore 
no correlation was found between the BMI z-score at 6 years and the percentage of weight 
loss (p=0.062, r=0.238). Median weight loss during residential treatment was – 46,6 
percent (range +4,4 to – 111%; interquartile range -32 to – 59%).
CONCLUSION : Residential treatment of obesity in the Zeepreventorium is successful. In this 
small cohort, no association was found between BMI at 6 years and the amount of weight 






INTRODUCTION De neonatale screening naar aangeboren stofwisselingsziekten blijft 
in Vlaanderen beperkt tot een aanbod, waartegen de ouders zich kunnen verzetten. De 
auteurs vinden de actuele situatie te vrijblijvend en pleiten voor een algemene verplichting. 
Het is immers voldoende aangetoond dat de diagnosestelling van deze aandoeningen louter 
op basis van klinische tekens te laattijdig gesteld wordt, wanneer er reeds irreversiebele 
letsels opgetreden zijn.
METHOD Onderzoek van mogelijkheid tot algemene verplichting Gezien de nefaste gevolgen 
van uitstel van de diagnose voor de prognose van de aangetaste neonaat, kan men stellen 
dat in zijn actuele vrijblijvende vorm aan sommige patiëntjes het recht op een normaal 
leven ontnomen wordt. Alleen een algemene verplichting, waartegen de ouders zich niet 
kunnen verzetten op basis van hun ouderlijk gezag, geeft aan alle pasgeborene dezelfde 
kansen van vroegtijdige opsporing. Anderzijds kan een neonatale opsporing enkel verplicht 
worden als aangetoond kan worden dat deze inmenging in het privé- of gezinsleven niet 
als onrechtmatig of arbitrair kan bestempeld worden. Dit kan bezwaarlijk gesteld worden 
als van het recht op fysieke integriteit van de pasgeborene op het spel staat. In dezelfde 
zin is het recht op fysieke integriteit de motivatie om aan te tonen in artikel 8 van het 
Europees Verdrag van de Rechten van de Mens dat deze inmenging een noodzakelijke 
maatregel ter bescherming van de gezondheid vormt. Hierdoor is het openbaar gezag 
gemachtigd om zich in het privé- en gezinsleven te mengen. De Belgische Vereniging voor 
Kindergeneeskunde moet ijveren bij de wetgever voor een algemene verplichting en heeft 
daarbij een sleutelrol te vervullen.
CONCLUSION Rol van de Belgische Vereniging voor Kindergeneeskunde - De bevoegde 
overheid overtuigen van een algemene verplichting op basis van de bestaande literatuur. 
- De algemene bevolking en in het bijzonder de ouders van de pasgeborene grondig 
informeren omtrent de neonatale screening om de bestaande kennisasymmetrie uit te 
vlakken. - Het streven naar gelijkvormigheid van het aantal screeningstesten over het 
ganse land. - Het wetenschappelijk onderzoek promoten om de testmethoden te blijven 
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INTRODUCTION Severe stenosis of pulmonary arteries are frequently diagnosed after 
surgical repair of complex congenital cardiac malformations in newborns. Such residual 
lesions often require multiple catheterizations for pulmonary artery rehabilitation through 
balloon dilations and stenting. Premounted Edwards Valeo Life stents, designed for biliary 
tract stenosis, have an open-cell design allowing repeated dilations up to 18 mm, through 
small (6 Fr) sheats, including in neonates. Such recent stents can accomodate secondary 
dilations to adult size, thereby avoiding surgery, and preserve the growing potential of 
vessels between dilations.
RESULTS A full term newborn was admitted with a prenatal diagnosis at 30 weeks with 
interrupted aortic arch (IAA), aortopulmonary window (APW), and an intra-operative 
diagnosis of abnormal origin of the right pulmonary artery (RPA), consistent with Berry’s 
syndrome. Since the first case described in 1982 by Berry, less than 30 cases were 
reported. On the 7th day of life (DOL) we performed a one-stage surgical repair consisting in 
an end-to-end anastomosis of the aortic arch, patch-closure of the APW and reimplantation 
of the RPA on the main pulmonary artery (MPA) with a tubular pericardial patch. During 
follow-up, on the 6th postoperative week, a complete occlusion of the RPA demonstrated 
by a lung scan and by catheterisation was dilated with coronary balloons up to 4 mm. 
Three weeks later, an echocardiogram showed re-occlusion of the RPA and an angiography 
demonstrated an extremely tight stenosis of the RPA origin, dilated with 4 mm Maverick 
and 5 mm Tyshak balloons. A 6x18 mm low-profile pre-mounted Edwards Valeo Lifestent 
was positioned and dilated up to 6 mm (fig 2), restoring a normal perfusion of the RPA, as 
also confirmed by a lung scan and color-Doppler showing no significant residual gradient.
CONCLUSION A newborn diagnosed with Berry’s syndrome underwent complete surgical 
repair on DOL 7 and subsequently developed an extremely tight RPA stenosis 6 weeks later. 
This complication, likely related to the necessary interposition of a tubular pericardial patch 
between the RPA and MPA, was successfully treated by balloon dilations and stenting with 
a 6 mm Edwards Valeo Lifestent. This technique allows repeat dilations up to an adult size 
RPA (18 mm), thereby avoiding a complex redo-surgery in a newborn.
